Academic Journal

Synthetic Design and Biological Evaluation of New p53-MDM2 Interaction Inhibitors Based on Imidazoline Core

التفاصيل البيبلوغرافية
العنوان: Synthetic Design and Biological Evaluation of New p53-MDM2 Interaction Inhibitors Based on Imidazoline Core
المؤلفون: Daniil R. Bazanov, Nikolay V. Pervushin, Egor V. Savin, Michael D. Tsymliakov, Anita I. Maksutova, Victoria Yu. Savitskaya, Sergey E. Sosonyuk, Yulia A. Gracheva, Michael Yu. Seliverstov, Natalia A. Lozinskaya, Gelina S. Kopeina
المصدر: Pharmaceuticals, Vol 15, Iss 4, p 444 (2022)
بيانات النشر: MDPI AG, 2022.
سنة النشر: 2022
المجموعة: LCC:Medicine
LCC:Pharmacy and materia medica
مصطلحات موضوعية: nutlins, cis-imidazolines, p53-MDM2 inhibitors, anti-cancer, Medicine, Pharmacy and materia medica, RS1-441
الوصف: The use of p53-MDM2 inhibitors is a prospective strategy in anti-cancer therapy for tumors expressing wild type p53 protein. In this study, we have applied a simple approach of two-step synthesis of imidazoline-based alkoxyaryl compounds, which are able to efficiently inhibit p53-MDM2 protein–protein interactions, promote accumulation of p53 and p53-inducible proteins in various cancer cell lines. Compounds 2l and 2k cause significant upregulation of p53 and p53-inducible proteins in five human cancer cell lines, one of which possesses overexpression of MDM2.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 1424-8247
Relation: https://www.mdpi.com/1424-8247/15/4/444; https://doaj.org/toc/1424-8247
DOI: 10.3390/ph15040444
URL الوصول: https://doaj.org/article/86381fec34274d868b2c6af77b718cf2
رقم الانضمام: edsdoj.86381fec34274d868b2c6af77b718cf2
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:14248247
DOI:10.3390/ph15040444